BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-6 out of 6 found
  Current Search:  epivir: 6     

HTML
100%
Entecavir Boosts Hepatitis B Response After Lamivudine Failure
TORONTO, July 1 -- Patients who were lamivudine (Epivir) refractory saw improved hepatitis B suppression that lasted through almost two years of treatment with entecavir (Baraclude).

The percentage of patients with fewer than 300 HBV...

MedPage Today:  Jul 1 2008 5:21PM
Matching: epivir
Find similar documents
HTML
100%
Nucleoside levels in seminal fluid higher than in blood, but not inside cells
Levels of the drugs AZT (zidovudine, Retrovir) and 3TC (lamivudine, Epivir) are generally higher in seminal fluid than they are in blood, a new study of these drugs' pharmacokinetics (PKs) has found.

However the researchers also...

Aidsmap:  Jun 18 2008 3:27PM
Matching: epivir
Find similar documents
HTML
100%
HAART Regimen Changes Due to Drug Toxicities in HIV Positive People with Virological Suppression
HAART Regimens Changes Due to Drug Toxicities in HIV Positive People with Virological Suppression Many prior studies have looked at switching various antiretroviral drug regimens due to virological failure or side effects, but few...
HIV and Hepatitis.com:  Jun 13 2008 10:34PM
Matching: epivir
Find similar documents
HTML
100%
Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term
HIV-positive patients with an undetectable viral load infrequently change their anti-HIV treatment because of side-effects nowadays, according to the results of a British study published in the May 31st edition of AIDS.

The study found...

Aidsmap:  May 29 2008 4:55AM
Matching: epivir
Find similar documents
HTML
100%
US study confirms long-term use of AZT, d4T result in lipoatrophy
Long-term use of AZT or d4T results in subcutaneous fat loss in the triceps, abdomen and thigh, whereas long-term abacavir use results in significant subcutaneous fat gain in the abdomen, according to the results of CPCRA 061 - a non...
Aidsmap:  May 27 2008 10:41AM
Matching: epivir
Find similar documents
HTML
100%
Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-H
Title: United States Patent: 7,354,906 Inventors: Sapse; Alfred T.

(Las Vegas, NV), Greeson; Janet (Las Vegas, NV) Assignee: Samaritan Pharmaceuticals, Inc.

(Las Vegas, NV) Appl.

No.: 10/918,737 Filed: August 16, 2004 The present...

PharmCast:  Apr 23 2008 12:11PM
Matching: epivir
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.